![]() |
市場調查報告書
商品編碼
1403434
2030 年錠劑包衣市場預測:按聚合物類型、類型、功能、最終用戶和地區進行的全球分析Tablet Coatings Market Forecasts to 2030 - Global Analysis By Polymer Type (Cellulosic Polymers, Vinyl Derivatives & Other Polymer Types), By Type (Enteric-coated Tablets, Film-coated Tablets & Other Types), Functionality, End User & By Geography |
根據 Stratistics MRC 的數據,2023 年全球錠劑包衣市場規模為 9.206 億美元,預計將以 7.6% 的複合年成長率成長,到 2030 年達到 15.373 億美元。
錠劑包衣是錠劑上的一層薄薄的聚合物或化合物。這些包衣具有多種用途,包括改善外觀、掩味、防止水分和光劣化、促進吞嚥、控制藥物釋放和提高穩定性。它在確保有效的藥物傳遞、最佳化患者依從性以及保持口服劑型中活性藥物成分的完整性方面發揮關鍵作用。
根據歐洲製藥工業和協會聯合會2022年的報告,2020年歐洲藥品產值為2866.97億歐元(3074168.80億美元),2021年為3000億歐元(3216.813億美元)。
製藥業的快速擴張一直是錠劑包衣市場的關鍵促進因素。在不斷變化的醫療保健需求和慢性病擴散的推動下,製藥業的成長正在推動對先進藥物配方的需求。錠劑包覆在提高藥物療效、患者依從性和產品差異化方面發揮著至關重要的作用。此外,隨著製藥公司追求創新的藥物傳輸系統,包覆可以實現緩釋性並推動包覆錠劑的採用。這種擴張為配方改進創造了機會,並推動了錠劑包衣市場的成長。
開發新配方或改進現有塗料需要較長的開發週期和廣泛的研究,這會增加成本並阻礙快速進入市場。配方核准和嚴格測試流程的延遲進一步延長了時間並影響了產品的發布。這些詳盡的程序不僅增加了開發成本,而且抑制了及時回應市場需求所需的敏捷性。這種抑制因素可能會限制創新並阻止中小企業進入市場,從而影響整個行業的成長。
不斷增加的研發投資為錠劑包覆市場創造了誘人的機會。增加研發投資將促進創新並促進先進塗層材料和技術的發展。研究的激增催生了新的配方,可改善藥物輸送、提高穩定性並滿足特定患者的需求。此外,它還可以創建環境永續的塗料,滿足對環保藥品日益成長的需求。這種投資的激增不僅將推動市場擴張,還將推動錠劑包覆向更有效率和客製化的解決方案發展。
應對複雜且不斷變化的法規對產品開發、核准和市場進入提出了重大挑戰。滿足嚴格的品質標準、文件要求和安全評估需要大量資源和時間,從而增加了開發成本。此外,監管變化可能會影響現有產品並需要進行調整。這些障礙阻礙和威脅錠劑包衣行業的成長和競爭力,阻礙創新,限制中小企業進入市場,並可能延遲先進包衣的引進。
COVID-19 的爆發擾亂了供應鏈並影響了生產計劃,從而影響了錠劑被覆劑市場。藥品需求的成長正在推動市場發展,但物流問題和勞動力限制等挑戰正在影響業務。此外,臨床試驗和監管流程的延遲也影響了新塗層的推出。該行業透過利用數位技術、強調遠端工作和實施安全措施進行了調整,但整體影響凸顯了該行業的彈性和適應性。
在預測期內,纖維素聚合物領域因其多功能特性預計將主導錠劑包衣市場。羥丙基甲基纖維素 (HPMC) 和乙基纖維素等纖維素衍生物具有優異的成膜能力、控制釋放特性和改進的藥物製劑穩定性。其生物相容性、安全性以及與各種藥物類型的相容性有助於其廣泛採用。此外,對天然和植物來源被覆劑不斷成長的需求預計將增強其市場主導地位,因為它們與纖維素聚合物的吸引力一致,使它們成為錠劑被覆劑的首選。
薄膜包衣錠劑預計在預測期內將出現顯著成長。薄膜包衣可增強錠劑的美觀,掩蓋不良味道,防止環境因素影響,並有助於提高患者的依從性。此外,它還可以實現控制釋放製劑並實現精確的藥物傳輸。此外,對患者友善劑型的需求不斷成長,以及薄膜包衣適應各種藥物配方的能力符合當前的製藥趨勢,並正在推動錠劑包衣市場這一細分市場的成長。
由於其強大的製藥基礎設施、廣泛的研發投資以及對創新藥物配方的關注,預計北美將主導錠劑包衣市場。有利的法律規範和高醫療保健支出進一步推動了市場成長。此外,該地區對緩釋製劑的需求不斷增加,加上慢性病的高發,推動了先進片劑緩釋性的錠劑。
由於製藥業的擴張、醫療保健支出的增加以及研發投資的增加,預計亞太地區的錠劑包衣市場將出現良好的成長,從而推動市場機會。此外,人口成長、生活方式的改變和慢性疾病的擴散正在推動藥品需求並刺激對先進錠劑包衣的需求。此外,大量受託製造廠商(CMO)和發達的醫療保健基礎設施也增強了亞太地區的吸引力,增加了該地區錠劑包衣的強勁成長預測。
According to Stratistics MRC, the Global Tablet Coatings Market is accounted for $920.6 million in 2023 and is expected to reach $1537.3 million by 2030 growing at a CAGR of 7.6% during the forecast period. Tablet coatings are thin layers of polymers or compounds on pharmaceutical tablets. These coatings serve multiple purposes, such as improving appearance, taste-masking, protecting against moisture or light degradation, facilitating swallowing, controlling drug release, and enhancing stability. They play a vital role in ensuring effective drug delivery, optimizing patient compliance and preserving the integrity of active pharmaceutical ingredients within oral dosage forms.
According to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the production of pharmaceuticals in Europe was valued at EUR 286,697 million (USD 30,7416.88) in 2020 and EUR 300,000 million (USD 321681.30) in 2021.
The rapid expansion of the pharmaceutical sector acts as a significant driver in the tablet coatings market. The pharmaceutical industry's growth, fueled by evolving healthcare needs and a surge in chronic diseases, propels the demand for advanced drug formulations. Tablet coatings play a pivotal role in enhancing drug efficacy, patient compliance and product differentiation. Moreover, as pharmaceutical companies strive for innovative drug delivery systems, coatings enable modified-release formulations, driving the adoption of coated tablets. This expansion creates opportunities for improved formulations, driving the growth of the tablet coatings market.
The lengthy development cycles and extensive research involved in creating new formulations or modifying existing coatings amplify costs and hinder rapid market entry. Delays in formulation approvals and stringent testing processes further extend the timeline, impacting product launches. These exhaustive procedures not only inflate development expenses but also impede the agility needed for timely responses to market demands. This restraint limits innovation and may deter smaller players from entering the market, affecting overall industry growth.
The escalating investment in research and development presents a compelling opportunity in the tablet coatings market. Increased R&D investments drive innovation, fostering the development of advanced coating materials and technologies. This surge in research leads to novel formulations that improve drug delivery, offer enhanced stability, and cater to specific patient needs. Moreover, it enables the creation of eco-friendly and sustainable coatings, aligning with the growing demand for environmentally conscious pharmaceutical products. This investment surge not only fosters market expansion but also promotes the evolution of tablet coatings towards more efficient and tailored solutions.
Compliance with complex and evolving regulations adds significant challenges to product development, approvals and market entry. Meeting stringent quality standards, documentation requirements and safety evaluations demands substantial resources and time increasing development costs. Moreover, changes in regulations can impact existing products, necessitating adaptations. These hurdles hinder innovation, limit market entry for smaller firms and potentially delay the introduction of advanced coatings, posing a threat by impeding growth and competitiveness within the tablet coatings industry.
The COVID-19 pandemic has influenced the tablet coatings market by disrupting supply chains and impacting production schedules. Increased demand for pharmaceuticals has driven the market, but challenges like logistical issues and workforce limitations have affected operations. Furthermore, delays in clinical trials and regulatory processes have impacted the introduction of new coatings. The industry has adapted through digital technologies, emphasizing remote work and implementing safety measures, but the overall impact underscores the sector's resilience and adaptability.
Over the forecast period, the cellulose polymers segment is expected to dominate the tablet coatings market due to their versatile properties. Cellulose derivatives like hydroxypropyl methylcellulose (HPMC) and ethyl cellulose offer excellent film-forming abilities, controlled-release properties and stability enhancement for pharmaceutical formulations. Their biocompatibility, safety, and suitability for various drug types contribute to their widespread adoption. Additionally, the growing demand for natural and plant-based coatings aligns with cellulose polymers' appeal, positioning them as favored choices for tablet coatings, thus driving their anticipated dominance in the market.
During the forecast period, the film-coated tablets segment is poised to witness significant growth. Film coatings enhance the aesthetic appeal of tablets, mask unpleasant tastes and protect against environmental factors, contributing to improved patient compliance. Moreover, they enable controlled-release formulations, ensuring precise drug delivery. Additionally, the rising demand for patient-friendly dosage forms and the ability of film coatings to accommodate various drug formulations align with current pharmaceutical trends, fostering the growth of this segment in the tablet coatings market.
North America is expected to dominate the tablet coatings market due to its robust pharmaceutical infrastructure, extensive R&D investments and strong emphasis on innovative drug formulations. Favorable regulatory frameworks and substantial healthcare expenditures further drive market growth. Additionally, the region's increasing demand for modified-release formulations, coupled with a high prevalence of chronic diseases, fuels the adoption of advanced tablet coatings.
Asia Pacific is poised to register lucrative growth in the tablet coatings market owing to the region's expanding pharmaceutical sector, rising healthcare expenditures, and increasing investments in R&D, which foster market opportunities. Additionally, a growing population, changing lifestyles and a surge in chronic diseases drive demand for pharmaceuticals, stimulating the need for advanced tablet coatings. Furthermore, the presence of a large pool of contract manufacturing organizations (CMOs) and improving healthcare infrastructure contribute to the region's attractiveness, fueling the projected robust growth of tablet coatings in Asia Pacific.
Some of the key players in tablet coatings market include Ashland Global Holdings Inc., BASF SE, Clariant AG, Coating Place, Inc., Colorcon, DOW Inc., DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., Ideal Cures Pvt. Ltd., JRS Pharma, Kerry Group, Merck KGaA, PPG Industries, Inc., Roquette Freres, Sensient Technologies Corporation and Shin-Etsu Chemical Co., Ltd.
In March 2023, Colorcon announced the launch of its new Soluplus® Encapsulation Technology. This technology is designed to improve the solubility and bioavailability of poorly water-soluble drugs.
In February 2023, Sensient Technologies announced the expansion of its tablet coating capabilities in the US. The company is investing $10 million in the expansion, which is expected to be completed by the end of 2023. The expansion will increase the company's tablet coating capacity by 50%.
In February 2022, JRS PHARMA introduced the solution for Titanium Dioxide free ready-to-use coatings, VIVACOAT® free.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.